Background Most published reports on early amniocentesis are of cohort
studies rather than randomised trials, This study was designed to ass
ess the safely and cytogenetic accuracy of early amniocentesis in cont
rast to midtrimester amniocentesis in a randomised multicentre setting
, Methods Pregnant women were randomly allocated early amniocentesis (
between 11(+0) and 12(+6) gestational weeks(days)) or midtrimester (be
tween 15(+0) and 16(+6) amniocentesis. A detailed fetal ultrasound exa
mination was done between 15 and 20 gestational weeks in ail women. Al
l amniocenteses were done under continuous ultrasound guidance: 11 mt
(early amniocentesis) or 20 mt (midtrimester amniocentesis) of amnioti
c fluid were removed for cytogenic analysis, No more than two needle i
nsertions were done on the same day, All fetal losses (spontaneous or
induced abortions) were counted as outcome events and post-procedural
losses had cytogenic analysis, Maternal and fetal health were assessed
at 20-22 weeks and 5 weeks after delivery, Logistic regression analys
is was used to assess the significance of the differences between the
early amniocentesis and midtrimester amniocentesis groups. Findings 43
74 pregnant women took part in the study, 1916 (87.8%) of 2183 women i
n the early amniocentesis group had their amniocentesis before 13 gest
ational weeks. 1775 (81.2%)) of 2185 women in the midtrimester group h
ad their amniocentesis after 15 gestational weeks, There was a signifi
cant difference in total fetal losses for early amniocentesis compared
with midtrimester amniocentesis (7.6% vs 5.9%; difference 1.7%, one-s
ided CI 2.98%, p=0.012). There was a significant increase in talipes e
quinovarus in the early amniocentesis group compared with the midtrime
ster amniocentesis group (1.3% vs 0.1%, p=0.0001). There was a signifi
cant difference in postprocedural amniotic-fluid leakage (early amnioc
entesis 3.5% vs midtrimester aminocentesis 1.7%, p=0.0007). Interpreta
tion Our study shows that early amniocentesis is associated with an in
creased risk of fetal loss and talipes equinovarus, Our results should
be taken into consideration when invasive prenatal diagnosis is being
offered.